In 2023, Spanoudaki et al. suggested that cancer risk and progression may be mediated by ET, which can enhance hormonal balance, insulin sensitivity, and immune cell function and mitigate many inflammatory and oxidative processes. The gene discussed is INS; the disease is cancer.